For the Inventor, By the Inventor

Enter inventor name

Los Angeles, CA, United States of America

Douglas C Saffran

USPTO Granted Patents = 41 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 5.6

ph-index = 15

Forward Citations = 630(Granted Patents)

Location History:

Encinitas, CA (US) (2007 - 2012)
Los Angeles, CA (US) (1996 - 2013)

Company Filing History:

5 out of 15,475

University of California

Genentech, Inc.

Urogenesys, Inc.

where one patent can have more than one assignee

Years Active: 1996-2013

Loading Chart...

Loading Chart...

Areas of Expertise:

Serpentine Transmembrane Antigens

Prostate Cancer

Tumor Detection

G Protein-Coupled Receptors

BPC-1 Protein

Prostate Stem Cell Antigen

Cancer Cell Expression

Antibodies to Cancer Proteins

Transmembrane Proteins

Nucleic Acids in Cancer

Peptides Derived from STEAP1

Hematopoietic Restricted Tyrosine Kinase

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8414898 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2013-04-09),

2. 8383777 - 13-transmembrane protein expressed in prostate cancer (2013-02-26),

3. 8241626 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2012-08-14),

4. 8236510 - Protein showing enhanced expression in cancer cells (2012-08-07),

5. 8053551 - Serpentine transmembrane antigens expressed in human cancers and uses therefor (2011-11-08),

6. 8003758 - BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells (2011-08-23),

7. 7981624 - Methods to detect tumors using 20P1F12/TMPRSS2 expression (2011-07-19),

8. 7968307 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2011-06-28),

9. 7947459 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2011-05-24),

10. 7928201 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2011-04-19),

11. 7858760 - Antibodies to protein expressed in prostate cancer (2010-12-28),

12. 7795391 - Protein showing enhanced expression in cancer cells (2010-09-14),

13. 7785811 - BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells (2010-08-31),

14. 7727533 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2010-06-01),

15. 7642054 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2010-01-05),

Title: The Innovative Journey of Douglas C Saffran

Introduction: Douglas C Saffran is a distinguished inventor based in Los Angeles, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Douglas C Saffran holds several patents in the areas of technology and healthcare, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning over two decades, Douglas C Saffran has been at the forefront of developing cutting-edge solutions that have significantly impacted industries worldwide.

Collaborations: Throughout his career, Douglas C Saffran has collaborated with leading experts in the field, fostering a culture of innovation and excellence in all his projects.

Conclusion: Douglas C Saffran's relentless pursuit of innovation and his passion for creating solutions that make a difference have solidified his reputation as a visionary inventor in Los Angeles, CA.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…